Standardisation of Target Volume Delineation for Carotid-sparing Intensity-modulated Radiotherapy in Early Glottis Cancer.
MetadataShow full item record
<label>AIMS</label>Recently, carotid-sparing intensity-modulated radiotherapy (IMRT) for early laryngeal glottis (T1/T2N0M0) cancer has generated interest in the hope of avoiding long-term carotid toxicity, as well as concerns relating to geographical misses and long-term normal tissue toxicity. The aim of this review was to summarise the current literature on carotid-sparing IMRT for early glottis cancer, with particular focus on definitions of target volumes and the carotid arteries as organs at risk. In addition, we make suggestions for standardisation of these structures, dose constraints and dose reporting.<label>MATERIALS AND METHODS</label>From 73 references, 16 articles met the criteria for inclusion in this systematic review. These papers described two case reports, 11 planning studies and three prospective studies.<label>RESULTS</label>There was variation in all target volume definitions with no clear consensus. The greatest variability was in clinical target volume definition. Carotid artery and spinal cord delineation were not always defined and most studies did not use a carotid artery constraint. Of the eight studies that reported carotid artery delineation, no two studies delineated the same length of carotid artery, yet most studies reported mean doses. Most studies used IMRT with three to seven fields. Five studies used arc therapy and two studies used tomotherapy.<label>CONCLUSION</label>This review highlights a lack of consensus in target volume definitions in carotid-sparing IMRT. Ultimately, long-term prospective data are required to show the benefit of carotid-sparing IMRT. Pooled data will prove useful as most studies will report on small numbers of patients. Therefore, adopting a consensus now on target volume definition, dose constraints and dose reporting will be crucial.
Version of record
Radiotherapy Planning, Computer-Assisted
License start date
Clinical oncology (Royal College of Radiologists (Great Britain)), 2017, 29 (1), pp. 42 - 50
Showing items related by title, author, creator and subject.
Metastasis-directed Therapy in Treating Nodal Oligorecurrent Prostate Cancer: A Multi-institutional Analysis Comparing the Outcome and Toxicity of Stereotactic Body Radiotherapy and Elective Nodal Radiotherapy. De Bleser, E; Jereczek-Fossa, BA; Pasquier, D; Zilli, T; Van As, N; Siva, S; Fodor, A; Dirix, P; Gomez-Iturriaga, A; Trippa, F; Detti, B; Ingrosso, G; Triggiani, L; Bruni, A; Alongi, F; Reynders, D; De Meerleer, G; Surgo, A; Loukili, K; Miralbell, R; Silva, P; Chander, S; Di Muzio, NG; Maranzano, E; Francolini, G; Lancia, A; Tree, A; Deantoni, CL; Ponti, E; Marvaso, G; Goetghebeur, E; Ost, P (2019-12)BACKGROUND:Stereotactic body radiotherapy (SBRT) and elective nodal radiotherapy (ENRT) are being investigated as metastasis-directed treatments in oligorecurrent prostate cancer (PC); however, comparative data are still ...
A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer. Murray, J; Griffin, C; Gulliford, S; Syndikus, I; Staffurth, J; Panades, M; Scrase, C; Parker, C; Khoo, V; Dean, J; Mayles, H; Mayles, P; Thomas, S; Naismith, O; Baker, A; Mossop, H; Cruickshank, C; Hall, E; Dearnaley, D; CHHiP Investigators (2020-01)BACKGROUND AND PURPOSE:Image-guided radiotherapy (IGRT) improves treatment set-up accuracy and provides the opportunity to reduce target volume margins. We introduced IGRT methods using standard (IGRT-S) or reduced (IGRT-R) ...